
SINGULAIR Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com
The "SINGULAIR Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.
SINGULAIR Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on SINGULAIR and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
Topics Covered
- Profile for SINGULAIR
- US Patents
- Expired US Patents
- Paragraph IV Patent Challenges
- US District Court Litigation
- International (ex US) Patents
- Supplementary Protection Certificates
- Clinical Trials
- Drug Prices - Average Pharmacy Cost
- Drug Prices - Best Wholesale Price
- Annual Sales Revenues
- Finished Product Suppliers
- Bulk API Sources
Companies Featured
- Merck Sharp & Dohme Corp.
- Msd Merck Co
- Prasco Laboratories
- Rebel Distributors Corp
- Bryant Ranch Prepack
- Dispensing Solutions Inc.
- Novoseek
- Abi Chem
- Chemmol
- Chembase.Cn
- Acesobio
- Act Chemical
- An Pharmatech
- Avachem Scientific
- Race Chemical
- Akos Consulting & Solutions
- Boc Sciences
- Zinc
- Targetmol
- Achemo Scientific Limited
- Clearsynth
- Molepedia
- Ichemical Technology USA Inc
- Pi Chemicals
- Acorn Pharmatech Product List
- Labseeker
- Ochem
- Labnetwork
- A Wuxi Apptec Company
- Chemieliva Pharmaceutical Co. Ltd
- Molport
- Musechem
- Biochempartner
- Hairui Chemical
For more information about this report visit https://www.researchandmarkets.com/research/k396cj/singulair_drug?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005402/en/
Editor Details
-
Company:
- Business Wire
- Website: